CRISPR Therapeutics AG
Long

CRSP – Biotech Breakout After Insider Accumulation | Seed System

113
CRSP just cleared its Darvas Box top with momentum, volume, and trend all aligning.

Seed System confirmation:

Darvas Box breakout at $56–58

Massive volume surge following insider/institutional buying (ARK, UBS, T. Rowe)

EMA stack bullish (9 > 21 > 50)

VWMA trending up, price riding the band

MACD bullish cross, RSI moving through 70

Setup:

Entry Zone: $60.00–62.00 (watch for pullback)

Stop Loss: $58.00

Target 1: $70.00

Target 2: $80.00+

Catalyst: Positive CTX310 gene therapy results (LDL & triglyceride drops up to 80%), and biotech sector strength. RS Rating now 85 — breakout quality.

Expecting a retest of the breakout before continuation. Strong long setup if biotech sector holds.

Declinazione di responsabilità

Le informazioni ed i contenuti pubblicati non costituiscono in alcun modo una sollecitazione ad investire o ad operare nei mercati finanziari. Non sono inoltre fornite o supportate da TradingView. Maggiori dettagli nelle Condizioni d'uso.